Article
Current and Evolving Treatments of Genotype 1 Hepatitis C Virus.
Gastroenterology clinics of North America - 1 Dec 2015
Alqahtani Saleh, Sulkowski Mark
Abstract excerpt
Development of antiviral agents that target the hepatitis C virus (HCV) has improved the success and tolerability of treatment, especially for patients with HCV genotype 1 infection. The new treatment options mean that clinicians are better able to prevent complications from chronic HCV infection. The field of direct-acting antiviral therapies for HCV infection continues to advance at a rapid pace, and many more...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
